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Dys-synchronyAbstract Background: Patients with COPD are frequently hospitalized for acute exacerbations
(AECOPD), which may cause respiratory failure and death. Proportional assist ventilation
(PAV) is a relatively new mode of ventilator-based, inspiratory support designed to assist sponta-
neous breathing in patients with intact neural drive. It is a form of synchronized partial ventilatory
assistance with peculiar characteristic that ventilator generates pressure in proportion to patient’s
instantaneous effort. Pressure support ventilation (PSV) is an attractive weaning mode, however
at higher pressure support levels, many patients displayed expiratory muscle activation indicating
that the patient is ‘‘ﬁghting the ventilator’’.
Objective: To compare PAV and PSV in the weaning of AECOPD patients.
Patients and methods: The study was conducted on 60 patients admitted to the Department of
Critical Care Medicine, at the Alexandria Main University Hospital with the diagnosis of
AECOPD. Exclusion criteria included those with severe cardiac or neurological disease, and those
managed by non-invasive ventilation. All patients were subjected on admission to complete history
taking, complete physical examination and laboratory investigations and were treated according to
guidelines of treatment of AECOPD. At the time of weaning patients were randomly categorized
into two equal groups; Group A: patients weaned using PAV and Group B: patients weaned using
644 A.A. Elganady et al.PSV and the two groups were assessed for weaning success, patient–ventilator dys-synchrony, MV
days, ICU, and hospital stay.
Results: The weaning success rate was 90% in group A, and 66.7% in group B. PAV was asso-
ciated with less patient–ventilator dys-synchrony and was associated with 1.5 day reduction in the
mean days of mechanical ventilation, 2 day reduction in the mean days of ICU stay, and 1.8 day
reduction in the mean days of hospital stay in comparison to PSV group.
Conclusion: PAV was associated with less patient–ventilator dys-synchrony and associated with
reduction of days of mechanical ventilation, ICU, and hospital stay.
ª 2014 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. Open access under CC BY-NC-ND license.Introduction
The Global Initiative for Chronic Obstructive Lung Disease
(GOLD) deﬁnes an acute exacerbation of chronic obstructive
pulmonary disease (AECOPD) as an acute increase in symp-
toms beyond normal day-to-day variation [1,2]. This generally
includes one or more of three cardinal symptoms: cough in-
creases in frequency and severity, sputum production increases
in volume and/or changes character, and/or dyspnea increases
[3,4].
In stage IV (Very Severe COPD), the most important sign
of AECOPD is a change in the mental status of the patient
and [5,6] in the presence of severe underlying airﬂow obstruc-
tion, an exacerbation can cause respiratory failure [1]. The
main objective of mechanical ventilation here is to maintain
both adequate oxygenation and ventilation, reduces the work
of breathing (WOB) and improves the comfort of the patient
until the condition that forced the need for this technique
has been reversed or alleviated. In an effort to meet these
objectives, a variety of ventilatory modes have been developed
that can potentially reduce complications, shorten the duration
of mechanical ventilation and thus improve clinical outcomes
[7].
So long has pressure support ventilation (PSV) been an
attractive weaning method because the patient has control
over the respiratory frequency and the depth, length, and ﬂow
of each breath. During PSV, each breath is augmented by
inspiratory pressure which is set by the clinician. The patient
triggers each inspiration, which continues until the inspiratory
ﬂow decreases to a system-speciﬁc minimal level. Exhalation
follows. The tidal volume is determined by the pressure
support level, effort, and mechanics [8].
During weaning with PSV, the clinician gradually reduces
the PS level as long as an appropriate spontaneous respiratory
rate and VT are maintained and distress is not evident. When
PS is reduced to about 5 cm H2O, the pressure level is not high
enough to contribute signiﬁcantly to ventilatory support.
However, this level of PS usually is sufﬁcient to overcome
the work imposed by the ventilator system (i.e., the resistance
of the ET, trigger sensitivity, demand-ﬂow capabilities, and the
type of humidiﬁer used) [9,10].
Proportional assist ventilation (PAV) is a relatively new
mode of ventilator-based, inspiratory support designed to as-
sist spontaneous breathing in patients with intact neural drive.
It was invented by M. Younes in the North America in 1992. It
has been under experimental and clinical investigation since
then. It is a form of synchronized partial ventilatory assistance
with peculiar characteristic that ventilator generates pressurein proportion to patient’s instantaneous effort. The more the
patient pulls, the more pressure the machine generates. Thus,
the ventilator ampliﬁes the patient’s inspiratory effort without
any pre-selected target volume or pressure. It allows the pa-
tients to attain whatever ventilator and breathing pattern seem
to ﬁt the ventilatory control system and different clinical con-
ditions. It is regarded as an ‘‘additional respiratory muscle’’
which takes over certain proportion of ventilatory workload,
under the complete control of the patient’s ventilatory drive.
That is to say, unlike all other forms of assisted ventilation
(e.g. volume controlled, pressure controlled), there is no target
ﬂow, volume, or airway pressure and the responsibility of
guiding the ventilatory pattern is shifted completely from clini-
cians to patients, with the purpose of improving the patient–
ventilator interaction [11].
Studies performed with PAV+ have revealed that, com-
pared with conventional modes, its application is simple and
time saving, while it may more effectively reduce patient–
ventilator dys-synchrony, facilitate weaning and improve sleep
quality in critically ill patients but with limited studies in wean-
ing mechanically ventilated COPD patients [12].
So in our study we aimed to compare PAV and PSV in
weaning mechanically ventilated patients with AECOPD for
a better knowledge of the best weaning modality that could
help improving the general management of such COPD pa-
tients and, ultimately, lead to a greater rate of discontinuation
of mechanical ventilation.
Patients and methods
This study was conducted on 60 adult patients; according to
sample size calculation, who were admitted to the Critical Care
Medicine Departments in Alexandria Main University Hospi-
tal with the diagnosis of acute exacerbation of COPD and indi-
cated for invasive mechanical ventilation. Patients were
excluded for reasons as follows: pregnancy, hemodynamic
instability, severe neurological disease hindering the respira-
tory drive, and patients on mechanical ventilation for less than
24 h (including self extubation or death).
Informed consent was taken from ﬁrst degree relative of
every patient included in the study. The research was approved
from the Ethics Committee of Alexandria faculty of medicine.
All selected patients fulﬁlling the inclusion criteria were sub-
jected to the following on admission: demographic data includ-
ing: age, sex and height, history, physical examination, chest
examination, plain bedside antero-posterior chest X-ray,
arterial blood gas (ABG) analysis, and oxygenation index
(PaO2/FiO2). Routine ICU investigations were done on admis-
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rected. All patients were managed according to standard pro-
tocols of the management of acute exacerbation of COPD
patients [1].
All patients were sedated and mechanically ventilated using
a microprocessor-controlled mechanical ventilator (Galileo
GOLD; Hamilton Medical AG, Bonaduz, Switzerland) using
an assisted volume-controlled ventilation mode with suitable
settings according to patients’ needs. Weaning was decided
when following weaning criteria were met: [8,13,14]
1. Reversal of the cause of mechanical ventilation.
2. Hemodynamic stability: that is, no clinically important
hypotension and no requirement for vasopressors or a
requirement only for low-dose vasopressor therapy (e.g.,
dopamine or dobutamine <5 l/kg/min).
3. Patient capable of initiating an inspiratory effort.
4. Adequate oxygenation: arterial partial pressure of oxygen
(PaO2) P60 mmHg with fractional inspired oxygen (FiO2)
<0.4, ratio of arterial partial pressure of oxygen to frac-
tional inspired oxygen (PaO2/FiO2) P150–200 mmHg,
required positive end expiratory pressure (PEEP) <5–
8 cm H2O, FiO2 <0.4–0.5.
5. Heart rate <120, respiratory rate <35, pH > 7.35, tidal
volume (VT) >5 ml/kg, rapid shallow breathing index
(RSBI) (respiratory rate/tidal volume) <105, minute vol-
ume < 10 L/min.
6. No electrolyte disturbances, no sedation or narcotics.
7. Good nutritional status and no clinically evident myopathy
or neuropathy.
8. Corrected reversible causes of weaning failure such as sepsis
or heart failure.
According to the weaning method used, patients were ran-
domly categorized using the closed envelope method into two
groups:
 Group A: Including (30) patients who were weaned using
proportional assist ventilation mode with the following
steps:
1. Entering the correct ideal body weight (IBW), endotra-
cheal tube (ETT) size and maximum airway pressure
(MAP) limit (40 cm H2O).
2. Initial settings of PEEP and FiO2 were done by the usual
criteria.
3. Setting the percentage % of assist starting at 70% assist.
4. Monitoring the patient for respiratory distress which
included two or more of the following (heart rate
>120% of the usual rate for >5 min and/or systolic
blood pressure >180 or <90 mmHg and/or systolic
BP changes >20% of the previous value for >5 min,
RR >40 bpm for >5 min, marked use of respiratory
muscles, diaphoresis, abdominal paradox, patient com-
plaints of dyspnea).
5. If no respiratory distress, the assist was reduced by 10–
20% every 2 h with monitoring of respiratory distress.
6. If no respiratory distress at 10–20% assists, extubation
was considered.
 Group B: Including (30) patients who were weaned
using pressure support ventilation mode with the following
steps:1. Starting spontaneous breathing trial with low level of
continuous positive airway pressure (e.g., 5 cm H2O)
and low level of pressure support (e.g., 5–8 cm H2O).
2. The initial few minutes of the trial should be closely
monitored for respiratory distress and tolerance before
a decision is made to continue.
3. If no signs of respiratory distress or intolerance are evi-
dent, the patient should continue the trial to 30 min.
4. If no signs of distress, the trial will be continued for
120 min.
5. If no signs of distress at 120 min, extubation will be
considered.
6. If the patient is unable to tolerate or distressed, the
patient is fully rested until the next day when the process
begins again.
Vital signs and rapid shallow breathing index (RSBI) (respi-
ratory rate/tidal volume) were monitored in both groups dur-
ing the weaning process for assessment of success. ABG was
done 1 h after start of weaning and before extubation. Work
of breathing (in J/L) was calculated for both groups before
extubation. Patients in the two groups were assessed for the
following outcomes:
1. Weaning success as deﬁned as absence of tachypnea >35,
tachycardia >120, PaO2/FiO2 >150, hemodynamic stabil-
ity (no clinically important hypotension and no require-
ment for vasopressors or a requirement only for a low
dose vasopressor therapy (e.g., dopamine or dobutamine
<5 l/kg/min), pH >7.32, and patient is not re-intubated
and ventilated within 72 h of extubation [15].
2. Patient–ventilator dys-synchrony: including triggering, ﬂow
and cyclic dys-synchrony. It was detected visually on 30-
min recordings of ﬂow and airway pressure curves during
the weaning period and compared in the two groups using
asynchrony index (deﬁned as the percentage of asynchro-
nous to total breaths during recording period) [16].
3. Days of mechanical ventilation.
4. Length of ICU stay.
5. Length of hospital stay.
6. 28-day Mortality rate.
Statistical analysis of the data
Data were analyzed using IBM SPSS software package version
20.0. Qualitative data were described using number and per-
cent. Quantitative data were described using mean, standard
deviation median, minimum and maximum. Comparison be-
tween different groups regarding categorical variables was
tested using Chi-square test. When more than 20% of the cells
have expected count less than 5, correction for chi-square was
conducted using Fisher’s Exact test or Monte Carlo correction.
The distributions of quantitative variables were tested for
normality using Kolmogorov–Smirnov test, Shapiro–Wilk test
and D’Agstino test, also Histogram and QQ plot were used for
vision test. If it revealed normal data distribution, parametric
tests were applied. If the data were abnormally distributed,
non-parametric tests were used. For normally distributed data,
comparison between two independent populations was done
using independent t-test. For abnormally distributed data,
Table 1 Demographic and clinical criteria on admission in both studied groups.
Variable: Mean ± SD PAV (n= 30) PSV (n= 30) Test of signiﬁcance
Age 58.13 ± 7.74 61.20 ± 6.01 tp= 0.092
Male sex (number) 25 24 v2p= 0.739
Height 179.63 ± 4.60 177.23 ± 6.22 tp= 0.095
Precipitating factor (N)
Chest infection 30 27 p= 0.237
Irritants 0 3
Vital signs
Heart rate 93.20 ± 14.54 98.83 ± 7.62 p= 0.067
Respiratory rate 28.17 ± 2.49 26.10 ± 2.51 p= 0.104
Temperature 37.74 ± 0.42 37.92 ± 0.39 p= 0.092
Mean arterial blood pressure 98.67 ± 9.99 103.40 ± 9.0 p= 0.059
Arterial blood gases
PH 7.21 ± 0.05 7.20 ± 0.11 p= 0.575
PCO2 56.0 ± 15.18 52.13 ± 11.77 p= 0.275
PO2 100.58 ± 16.31 101.80 ± 26.22 p= 0.830
HCO3 39.70 ± 3.24 38.40 ± 3.45 p= 0.138
SaO2 81.43 ± 3.83 81.30 ± 3.69 p= 0.891
Hypoxic index 124.97 ± 23.63 120.50 ± 23.17 p= 0.463
PAV: proportional assist ventilation, group (A).
PSV: pressure support ventilation, group (B).
p: p value for comparison between the two studied groups.
v2: Chi square test.
t: Student’s t-test.
Table 2 Eligibility weaning criteria in both studied groups.
Variable: mean ± SD PAV (n= 30) PSV (n= 30) Test of signiﬁcance
Arterial blood gases
PH 7.42 ± 0.03 7.44 ± 0.04 p= 0.080
PCO2 58.30 ± 8.29 62.30 ± 9.84 p= 0.094
PO2 75.37 ± 16.61 81.27 ± 13.80 p= 0.140
HCO3 36.46 ± 5.61 38.47 ± 3.64 p= 0.107
SaO2 93.37 ± 1.65 93.93 ± 1.44 p= 0.161
Ventilatory data
TV 530.67 ± 51.79 539.0 ± 45.44 p= 0.510
MV 9.62 ± 0.92 9.27 ± 0.86 p= 0.132
FiO2 0.34 ± 0.05 0.34 ± 0.05 p= 0.605
RSBI 47.67 ± 18.81 37.70 ± 17.23 MWp= 0.051
Hypoxic index 220.70 ± 42.81 232.43 ± 33.67 tp= 0.243
Investigations
Na+ 138.60 ± 3.45 138.20 ± 5.52 tp= 0.738
K+ 4.59 ± 0.49 4.59 ± 0.49 MWp= 1.000
Serum albumin 3.71 ± 0.39 3.71 ± 0.34 tp= 1.000
Vital signs
Heart rate 90.20 ± 11.58 88.67 ± 9.32 p= 0.574
Respiratory rate 18.0 ± 1.53 17.63 ± 1.45 p= 0.345
Temperature 37.11 ± 0.26 37.18 ± 0.37 p= 0.129
Mean arterial blood pressure 94.33 ± 3.92 91.87 ± 6.82 p= 0.093
PAV: proportional assist ventilation, group (A).
PSV: pressure support ventilation, group (B).
p: p value for comparison between the two studied groups.
MW: Mann–Whitney test.
t: Student’s t-test.
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using Mann–Whitney test. Signiﬁcance test results are quoted
as two-tailed probabilities. Signiﬁcance of the obtained results
was judged at the 5% level.Results
Both groups were homogenous in their age and height distri-
bution. Majority were males. Chest infection was the main pre-
cipitating factor of AECOPD, except for three patients (10%)
in group B, where the precipitating factor was irritants. Vital
signs, ABG and hypoxic index on admission did not show sig-
niﬁcant differences between the two studied groups; (Table 1).
As regards pre-weaning data; namely ABG, ventilatory
data, RSBI, hypoxic index, investigations, and vital signs, they
showed improvement toward weaning without signiﬁcant dif-
ferences between both studied groups; (Table 2).
During the weaning period there was no signiﬁcant differ-
ence between both groups as regards ABG, RSBI (1 h after
start of weaning), hypoxic index, work of breathing, or mean
vital signs. Ineffective triggering was the most common cause
of dys-synchrony followed by cyclic dys-synchrony; both were
signiﬁcantly noticed in PSV group (B). Flow dys-synchrony,
although occurred, was not signiﬁcant when compared in bothTable 3 Weaning data in both studied groups.
Variable: mean ± SD. PAV (n= 30)
Arterial blood gases
PH 7.41 ± 0.02
PCO2 55.53 ± 7.82
PO2 79.60 ± 12.53
HCO3 35.60 ± 5.35
SaO2 93.93 ± 1.82
Ventilatory data
RSBI 44.53 ± 14.53
Hypoxic index 232.20 ± 46.27
Work of breathing (J/L) 0.47 ± 0.07
Vital signs
Heart rate 88.67 ± 9.32
Respiratory rate 16.63 ± 1.63
Temperature 37.11 ± 0.37
Mean arterial blood pressure 91.87 ± 6.82
Patient–ventilator dys-synchrony
Flow dys-synchrony 1 (3.3%)
Cyclic dys-synchrony 1 (3.3%)
Triggering dys-synchrony 4 (13.3%)
Asynchrony index
<5 27 (90%)
P5 & <10 3 (10%)
P10 0 (0.0%)
PAV: proportional assist ventilation, group (A).
PSV: pressure support ventilation, group (B).
p: p value for comparsion between the two studied groups.
MW: Mann–Whitney test.
v2: Chi square test.
MC: Monte Carlo test.
FE: Fisher Exact test.
T: Student’s t-test.
*Statistically signiﬁcant at p 6 0.05.groups. An asynchrony index of (P5 & <10) and (P10) was
less signiﬁcantly encountered in PAV group (A), while an
asynchrony index of (<5) was more signiﬁcantly encountered
in the same group; Table 3.
Outcome measures (Table 4)
Weaning success parameters (respiratory rate, heart rate, pH,
hypoxic index, no re-intubation) were signiﬁcantly better in
PAV group (A). Weaning success rate was 90% in group A
versus 66.7% in group B. The difference was statistically
signiﬁcant.
Total days of mechanical ventilation in the successfully
weaned patients were signiﬁcantly less in PAV group (A)
(p< 0.001). ICU and hospital stay were signiﬁcantly less in
PAV group as well (p< 0.001). No signiﬁcant difference was
found between both groups as regards 28-day mortality
(p= 1.000).
Discussion
The gradual withdrawal of PSV is a poor predictor of a pa-
tient’s ability to sustain ventilation after extubation. This
was illustrated by Nathan et al. [17] who reduced the level ofPSV (n= 30) Test of signiﬁcance
7.42 ± 0.04 p= 0.273
59.67 ± 10.21 p= 0.084
86.67 ± 12.83 p= 0.353
37.18 ± 3.74 p= 0.192
93.93 ± 1.82 p= 1.000
37.57 ± 13.25 MWp= 0.057
235.63 ± 46.30 tp= 0.775
0.48 ± 0.08 p= 0.559
90.20 ± 11.58 p= 0.574
16.03 ± 1.61 p= 0.156
37.26 ± 0.26 p= 0.129
94.33 ± 3.92 p= 0.093
3 (10%) FEp= 0.612
9 (30%) v2p= 0.006*
11 (36.7%) v2p= 0.037*
17 (56.7%) MCp= 0.003*
5 (16.7%)
8 (26.7%)
648 A.A. Elganady et al.PSV step-wise and compared the corresponding tidal volumes
among patients who weaned successfully versus patients who
failed weaning. The tidal volumes in the two groups over-
lapped signiﬁcantly at each level of PSV.
Evidence justifying the role of PAV in mechanically venti-
lated COPD patients is yet to be fully demonstrated although
PAV has been tested in many situations such as weaning of
chronically ventilated patients, acute respiratory failure, and
acute cardiogenic pulmonary edema in addition, as a non
invasive tool for assessing sleep quality in mechanically venti-
lated patients and exercise capacity in severe COPD patients
[18–20].
As regards the baseline parameters including the demo-
graphic data, vital signs on admission and etiological diagnosis
of respiratory failure, which were not signiﬁcant in our study,
were not also signiﬁcant in the study of Fernandez-Vivas et al.
[20] about non-invasive pressure support versus proportional
assist ventilation in acute respiratory failure.
Pre-weaning ventilatory parameters in the present study
such as tidal volume, minute ventilation, FiO2, and RSBI were
almost similar in both groups and also the pre-weaning ABG
and HI showed no signiﬁcant difference between the two
groups which was in agreement with a recent study of Aguir-
re-Bermeo et al. [21] who compared tolerance, duration of
mechanical ventilation (MV) and clinical outcomes during
weaning from MV in patients subjected to either pressure sup-
port ventilation (PSV) or proportional assist ventilation (PAV)
in 40 mechanically ventilated critically ill patients.Table 4 Outcome measures in both studied groups.
Variable (number) PAV (n= 30)
Weaning success parameters
Respiratory rate <35 27 (90%)
Heart rate <120 27 (90%)
PH > 7.32 27 (90%)
Hypoxic index >150 27 (90%)
No re-intubation 27 (90%)
Weaning success
Success 27 (90%)
Failure 3 (10%)
MV days: mean ± SD
Success group 2.43 ± 0.91
Failure group 6.33 ± 0.58
ICU stay: mean ± SD
Success group 3.70 ± 0.94
Failure group 8.33 ± 0.58
Hospital stay: mean ± SD
Success group 4.81 ± 1.24
Failure group 9.67 ± 0.58
28 day mortality (number)
Survived 29 (96.7%)
Died 1 (3.3%)
PAV: proportional assist ventilation, group (A).
PSV: pressure support ventilation, group (B).
p: p value for comparsion between the two studied groups.
v2: Chi square test.
*Statistically signiﬁcant at p 6 0.05.The ﬁnding that there were no signiﬁcant differences be-
tween the two groups regarding the hemodynamic parameters
(heart rate and the mean arterial blood pressure), ABG and
hypoxemia either at the baseline, during, or at the end of the
trial, is matching with results obtained by Costa et al. [18],
who conducted a physiological comparison between PAV+
and PSV in difﬁcult to wean patients.
In the current study there were three patients (10%) with
weaning failure in PAV group, versus ten patients (33.3%) in
PSV group. This was attributed to the higher rate of pa-
tient–ventilator dys-synchrony encountered in PSV group.
There were ten patients (33.3%) re-intubated in PSV group
while only three patients (10%) in PAV group which was
mainly due to respiratory acidosis and to a lesser extent due
to hypoxemia. The patient–ventilator dys-synchrony was high-
er in PSV than PAV group which was mainly cyclic and trig-
gering dys-synchrony with high asynchrony index AI P10
was in PSV group. This was matching with Xirouchaki et al.
[22], who observed that ineffective triggering and double trig-
gering are the most common types of dys-synchrony in their
study with greater incidence in PSV than PAV group. Thille
et al. [16] reported that 24% of patients had asynchrony index
P10 in both the ACV and PSV groups and this was associated
with poor outcome.
As regards patient–ventilator dys-synchrony Xirouchaki
et al. [22] concluded that the proportion of patients exhibiting
major patient–ventilator dys-synchrony at least during one oc-
casion and after adjusting the initial ventilator settings, wasPSV (n= 30) Test of signiﬁcance
20 (66.7%) v2p= 0.028*
20 (66.7%) v2p= 0.028*
20 (66.7%) v2p= 0.028*
20 (66.7%) v2p= 0.028*
20 (66.7%) v2p= 0.028*
20 (66.7%) p= 0.028*
10 (33.3%)
3.85 ± 1.23 p< 0.001*
8.90 ± 0.88 p= 0.041*
5.45 ± 1.43 p< 0.001*
10.0 ± 1.05 p = 0.033*
6.65 ± 1.57 p< 0.001*
11.50 ± 1.60 p= 0.026*
28 (93.3%) p= 1.000
2 (6.7%)
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agreement with our study, so they concluded that PAV+
may be used as a useful mode of support in critically ill pa-
tients. Compared to PSV, PAV+ increases the probability of
remaining on spontaneous breathing, while it considerably re-
duces the incidence of patient–ventilator asynchronies.
In a recent study Hosking et al. [19], assessed the incidence
and types of patient–ventilator asynchrony in mechanically
ventilated patients on Assist Control (A/C), PSV and PAV
and evaluated whether PAV reduces patient–ventilator asyn-
chrony when compared to PS during protocol-based weaning.
Thirty-ﬁve patients mechanically ventilated >36 h meeting
speciﬁc eligibility criteria to start weaning were enrolled in
their study once they were able to trigger the ventilator and
asynchrony was detected visually by recordings of the ﬂow
and airway pressure tracings. The high asynchrony index
P10 was in 27% of cases in the high PSV group and in 6%
in the low PSV group with no cases showing high AI in the
PAV group at its different levels of assist and also the low
AI was in favor of the PAV group and so their conclusion is
that PAV reduces asynchrony at all levels of support.
The ﬁnding that days of mechanical ventilation in the suc-
cessfully weaned patients were signiﬁcantly less in PAV group
(A) with less ICU and hospital stay was in agreement with Xir-
ouchaki et al. [22] who investigated the efﬁcacy of PAV+ and
PSV in a randomized controlled study in a group of 208 criti-
cally ill patients, recovering from controlled MV. The patients
were randomized to receive PAV+ or PSV for 48 h, unless
they met failure criteria or were able to breathe without venti-
lator assistance. The main result of their study was that the
failure rate (patient switched back to controlled mode) during
the 48 h of trial was signiﬁcantly lower in the PAV+ group
compared to the PSV group.
No signiﬁcant difference was found between both groups as
regards 28-day mortality. In the PAV group one case died
from pulmonary embolism and two cases died in the PSV
group due to cardiac arrhythmia which was not related to their
COPD condition.
Conclusion
PAV was associated with less patient–ventilator dys-synchrony
when compared to PSV. So PAV was associated with reduc-
tion of mechanical ventilation days, ICU stay, and hospital
stay when used for weaning patients with AECOPD.Conﬂict of interest
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